Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
A new Northwestern Medicine study has uncovered herpes’ sneaky strategy for infecting the nervous system, opening a path to long-needed vaccine development for the virus.
Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.
Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, reducing muscle scarring in an animal model of the disease.
Stephanie Eisenbarth, MD, PhD, of Yale University, has been named chief of Feinberg’s Division of Allergy and Immunology in the Department of Medicine, and director of the newly formed Center for Human Immunobiology.
A team of Northwestern investigators has demonstrated that injection of anti-inflammatory peptide amphiphiles into intestinal lesions can reduce inflammation in an animal model of Crohn’s disease.
In late March, the world came to a virtual standstill. The COVID-19 pandemic forced leaders around the world to limit large gatherings and shutter schools and businesses. For Feinberg’s research enterprise, this was a serious disruption — but science kept moving forward.
A recent Northwestern Medicine study has revealed previously unknown details about calcium signaling that can contribute to inflammation.
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.